Hosted by ReachMD · 🇺🇸 US · EN · 41 episodes
Established thought leaders with verified media credentials.
Welcome to the Deep Breaths: Updates from CHEST series, dedicated to championing the prevention, diagnosis, and treatment of lung and chest diseases. Check out CHEST leaders and advocates sharing the latest in chest medicine education, clinical research, and team-based care in the areas of pulmonary diseases, critical care, and sleep medicine. Learn more about the latest diagnostic and treatment advances in pulmonology and critical care below.
ReachMD hosts Deep Breaths: Updates from CHEST, a science show with 41 episodes published.
Host: Stephanie Christenson, MD Guest: Diego Maselli, MD, FCCP COPD is increasingly recognized as a heterogeneous disease, and for a subset of patients, type 2 inflammation plays a meaningful role in exacerbation risk an
Guest: Ravi Kalhan, MD Guest: MeiLan K. Han, MD, MS For patients with chronic obstructive pulmonary disease (COPD), exacerbations are early indicators of disease progression—not just isolated events. In this expert-led d
Faculty: Rodolfo A. Estrada MD, FCCP Faculty: Steven M. Hollenberg, MD Faculty: Dana Kay, DO Subtle symptoms and overlooked risk factors can delay diagnosis of methamphetamine-associated pulmonary arterial hypertension (
Guest: Gerard A. Silvestri MD, MS, Master FCCP Guest: Mariam Alexander, MD, PhD Guest: Jessica S. Donington, MD, MSCR The 2025 European Society for Medical Oncology Congress and World Conference on Lung Cancer revealed s
Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Adam H. Fox, MD, MSc Guest: Anurag Singh, MD, PhD From updated surveillance strategies to evolving biopsy techniques and treatment advances, recent findings presented
Host: Diego Maselli, MD, FCCP Guest: Stephanie Christenson, MD Despite triple inhaled therapy, many patients with chronic obstructive pulmonary disease (COPD) continue to experience frequent and severe exacerbations, lea
Moderator: Amit Bobby Mahajan, MD, FCCP, DAABIP Guest: Jonathan Kurman, MD Guest: Surya Bhatt, MD New strategies like advanced pharmacologic agents and bronchoscopic lung volume reduction are redefining COPD and emphysem
Moderator: Gerard A. Silvestri MD, MS, Master FCCP Guest: Jessica S. Donington, MD, MSCR Guest: Mariam Alexander, MD, PhD Guest: Anurag Singh, MD Effective care for non-small cell lung cancer (NSCLC) now depends on early
Moderator: Gerard A. Silvestri MD, MS, Master FCCP Guest: Jessica S. Donington, MD, MSCR Guest: Mariam Alexander, MD, PhD Guest: Anurag Singh, MD Recent data from ASCO and ASTRO 2025 are redefining standards of care for
Host: Michael Ghobrial, MD Guest: Anju T Peters, MD, MSCI, FAAAAI Guest: Michael S. Blaiss, MD , FACAAI, FAAAAI Refractory chronic cough (RCC) is a debilitating condition that is often misunderstood and underdiagnosed, l
Host: Michael Ghobrial, MD Guest: Anju T Peters, MD, MSCI, FAAAAI Guest: Michael Blaiss, MD Refractory chronic cough can persist for years despite guideline-based therapy, significantly affecting patients’ physical, soci
Moderator: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN Guest: Bradford Bemiss, MD MSCR Guest: Debasree Banerjee, MD, MS, FCCP Effectively supporting patients with interstitial lung disease (ILD) requires more
Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Jeffrey B. Velotta, MD, FACS Guest: Anne Gonzalez, MD, M.Sc. For patients with non-small cell lung cancer, staging accuracy is critical in guiding treatment decisions
Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Fabien Maldonado, MD, FCCP Guest: Adam H. Fox, MD, MSc Cutting-edge biopsy methods and streamlined biomarker testing are transforming early-stage non-small cell lung c
Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Anurag Singh, MD Guest: Adam H. Fox, MD, MSc Guest: Mariam Alexander, MD, PhD Recent therapeutic advances are reshaping our approach to limited-stage small cell lung c
Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Anurag Singh, MD Guest: Adam H. Fox, MD, MSc Guest: Mariam Alexander, MD, PhD Despite the typically poor prognosis of extensive-stage small cell lung cancer, recent ad
Host: Diego Maselli, MD Guest: Monica Kraft, MD, FCCP Guest: Anju T Peters, MD, MSCI, FAAAAI IL-5 is a key driver of Type 2 inflammation in patients with severe asthma, promoting downstream effects like mucus plugging an
Host: Nathan Falk, MD, MBA, FAAFP Guest: Megan Conroy, MD, MA(Ed), FCCP Patients with chronic obstructive pulmonary disease (COPD) often experience significant delays in diagnosis and treatment due to systemic gaps in ma
Host: Nathan Falk, MD, MBA, FAAFP Guest: Ashwin Basavaraj, MD Early recognition and diagnosis of non-tuberculosis mycobacteria (NTM) and bronchiectasis are key for optimal patient management. However, these conditions ar
Guest: Ashwin Basavaraj, MD Guest: Keren Bakal, MD Guest: Nathan Falk, MD, MBA, FAAFP Guest: Amy Springer, NP Often mistaken for COPD or asthma, bronchiectasis and nontuberculous mycobacteria (NTM) can be difficult to re
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Deep Breaths: Updates from CHEST has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Deep Breaths: Updates from CHEST is hosted by ReachMD. The show is categorised under science (medicine) and has published 41 episodes.
Deep Breaths: Updates from CHEST has published 41 episodes.
Deep Breaths: Updates from CHEST regularly covers science, medicine, health. It sits in the science category, with a medicine focus.
Deep Breaths: Updates from CHEST is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Deep Breaths: Updates from CHEST hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Deep Breaths: Updates from CHEST average 17 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Deep Breaths: Updates from CHEST's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 7 days ago.
